These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11331176)

  • 1. Anesthetic management of toxic epidermal necrolysis: report of three adult cases.
    Rabito SF; Sultana S; Konefal TS; Candido KD
    J Clin Anesth; 2001 Mar; 13(2):133-7. PubMed ID: 11331176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent blisters in a case of resolving Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Chuang YN; Ho YY; Chiu TM
    Indian J Dermatol Venereol Leprol; 2014; 80(6):546-7. PubMed ID: 25382518
    [No Abstract]   [Full Text] [Related]  

  • 3. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drug-induced toxic epidermal necrolysis.
    Eisen ER; Fish J; Shear NH
    J Cutan Med Surg; 2000 Apr; 4(2):96-102. PubMed ID: 11179933
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis after phenytoin usage in a brain trauma patient.
    Schummer W; Schummer C; Kuwert C
    J Neurosurg Anesthesiol; 2002 Jul; 14(3):229-33. PubMed ID: 12172297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ecthyma gangrenosum in a patient with toxic epidermal necrolysis.
    Downey DM; O'Bryan MC; Burdette SD; Michael JR; Saxe JM
    J Burn Care Res; 2007; 28(1):198-202. PubMed ID: 17211226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival after a second episode of toxic epidermal necrolysis.
    Dreyfuss DA; Gottlieb LJ; Wilkerson DK; Parsons RW; Krizek TJ
    Ann Plast Surg; 1988 Feb; 20(2):146-7. PubMed ID: 3355061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin induced toxic epidermal necrolysis.
    Topcu H; Gokcinar D; Akcaboy ZN; Karabeyoglu I; Unal T
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S267-9. PubMed ID: 25518798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic epidermal necrolysis (Lyell syndrome).
    Roujeau JC; Chosidow O; Saiag P; Guillaume JC
    J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1039-58. PubMed ID: 2273103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic Epidermal Necrolysis in a Neurosurgical Patient.
    Sriganesh K; Das BP; Rao KVLN
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):374-376. PubMed ID: 28368912
    [No Abstract]   [Full Text] [Related]  

  • 15. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
    Wolkenstein P
    Therapie; 1996; 51(5):500-1. PubMed ID: 9138383
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
    Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
    J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.